The oxytetracycline TRED was developed through EPAs public participation process, which provides opportunities for public involvement in EPAs pesticide tolerance reassessment and reregistration programs. Developed in partnership with USDA and with input from EPAs advisory committees and others, the public participation process encourages public involvement starting early and continuing throughout the pesticide risk assessment and risk mitigation decision making process. The public participation process encompasses full, modified, and streamlined versions that enable EPA to tailor the level of review to the level of refinement of the risk assessments, as well as to the amount of use, risk, public concern, and complexity associated with each pesticide. Through the public participation process, EPA is making a commitment to both involve the public and meet statutory deadlines.